Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down Syndrome During the First Trimester
Completed
- Conditions
- Down Syndrome
- Registration Number
- NCT00287417
- Lead Sponsor
- University Hospital, Strasbourg, France
- Brief Summary
The aim of the study is to evaluate the risk of Down syndrome during the first trimester of the pregnancy. The risk assessment is evaluated using early ultrasound and maternal biochemical markers.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 20000
Inclusion Criteria
- Female > 18 years old
- Pregnant
Exclusion Criteria
- Maternal age < 18 years old, twin pregnancy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (7)
Service de Gynécologie-Obstétrique, SIHCUS, CMCO
🇫🇷Strasbourg, Alsace, France
Centre de Périnatalité, Hôpital Civil
🇫🇷Guebwiller, France
Département de Gynécologie-Obstétrique, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg
🇫🇷Strasbourg, Alsace, France
Centre Hospitalier
🇫🇷Belfort, France
Centre Hospitalier du Hasenrain
🇫🇷Mulhouse, France
Centre Mère et Enfant LE PARC, Service de Gynécologie Obstétrique
🇫🇷Colmar, France
Clinique ADASSA
🇫🇷Strasbourg, France